SSSefika Pinar Senol

Sefika Pinar Senol

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sefika Pinar Senol has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Inhibition of NOX2 Prevents Impairment of Cardiovascular Response and Inflammatory Tissue Injury Mediated by Nitrosative/ Oxidative Stress in the Lipopolysaccharide-Induced Septic Shock Model in Rats

    by Lutfiye Kara, Muhammed Ahmed-Reda Elosman, Sefika Pinar Senol, Elif İkIz, Parinaz Amini Didani, Tuba Kara, Bahar Tunctan

    Introduction: It is unknown whether inhibition of nicotinamide adenine dinucleotide phosphate oxidase (NOX) 2 has protective effects against the impaired cardiovascular response and inflammatory tissue injury mediated by nitrosative/ oxidative stress in bacterial septic shock. Therefore, using the NOX2 inhibitor NOX2ds-stat, the effects of NOX2 inhibition on cardiovascular response were explored in a rat septic shock model induced by lipopolysaccharide (LPS), in relation to cardiovascular/renal inflammatory tissue injury. Methods: Mean arterial pressure and heart rate were obtained non-invasively using a tail cuff device in rats before and at 1, 2, 3, and 4 hours after injection of saline or LPS. The rats were treated with NOX2ds-stat (0.1, 0.3, or 1 mg/kg) 1 hour following saline or LPS injection. The diazotization method was used to measure nitrite levels in the sera and cardiovascular/renal tissues. The changes in tissue expression of proteins and/or their phosphorylation status related to nuclear factor (NF)-κB/inducible nitric oxide synthase (iNOS)- and NOX2-mediated nitrosative/oxidative stress, as well as peroxisome proliferator-activated receptor (PPAR) α/β/γ, were assessed by the immunoblotting method. Using hematoxylin and eosin staining, histopathological changes in the tissues were evaluated. Results: A decrease in blood pressure by 48 mmHg and an increase in heart rate by 112 bpm were observed 4 hours after LPS injection. While the expression/ phosphorylation of gp91phox, p47phox, 3-nitrotyrosine, NF-κB p65, iNOS, Vasodilator- Stimulated Phosphoprotein (VASP), and interleukin (IL)-1β proteins was enhanced in the thoracic aorta, renal artery, heart, and kidney tissues, in addition to the levels of nitrite in the sera and tissues of LPS-injected animals, the expression/phosphorylation of endothelial nitric oxide synthase (eNOS), PPARα, PPARβ, and PPARγ was decreased. The LPS-induced changes were ameliorated by NOX2ds-stat (1 mg/kg). NOX2ds-stat also attenuated the LPS-induced increase in scores reflecting inflammatory tissue injury. Discussion: These findings indicate that selective inhibition of NOX2 prevents both impairment of cardiovascular response and cardiovascular/renal tissue injury, presumably through suppression of NF-κB/iNOS- and NOX2-mediated nitrosative/ oxidative stress associated with increased expression of anti-inflammatory PPARα/β/γ in the rat septic shock model induced by bacterial LPS. Further studies are required to determine whether NOX2 inhibition benefits patients with septic shock. Conclusion: This study provides novel insights into the pathophysiological mechanisms of septic shock and highlights the potential therapeutic value of targeting NOX2 to improve cardiovascular response and inflammatory tissue injury.

  • Open Access

    Effects of RIPK1 inhibitor necrostatin-1s on cardiovascular responses and inflammatory damage in a bilateral hind limb I/R injury model in rats

    by Elif Ikiz, Muhammed Ahmed-Reda Elosman, Sefika Pinar Senol, Tuba Kara, Bahar Tunctan

    Objectives : This study investigated the effects of the receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor necrostatin-1s (Nec-1s) on cardiovascular responses and inflammatory damage in a bilateral hind limb ischemia/reperfusion (I/R) injury model in rats. Methods : The I/R injury model consisted of 3 h of ischemia followed by 24 h of reperfusion. Nec-1s was injected intraperitoneally into the rats 1 h before reperfusion. Results : Nec-1s prevented the hypotensive and tachycardic responses to I/R. The I/R-induced increases in the expression or activity of RIPK1, RIPK3, mixed lineage kinase domain-like pseudokinase, high-mobility group box 1, inhibitor of κB kinase α/β/γ, inhibitor of κBα, nuclear factor-kB p65, inducible nitric oxide synthase, cyclooxygenase-2, and interleukin-1β in cardiac, renal, pulmonary, hepatic, and cerebral tissues, as well as in the serum nitrite and prostaglandin I 2 levels of the rats, were prevented by Nec-1s. Nec-1s attenuated the elevation in scores for I/R-induced histopathological changes only in the heart. Conclusion : These findings revealed that Nec-1s prevents the deterioration of cardiovascular responses and inflammatory tissue damage in a hind limb I/R model in rats.

  • Open Access

    Ebeliğe Özgü Farmakoloji

    by Zeliha Kerry, Arzu Erdal, Nur Akman, Şefika Pınar Şenol, Emine Nur Özbek, Yasemin Eraç, Güle Çınar, Gülnur Sevin, Gönen Özşarlak Sözer, Yasemin Öztürk

    W w w. a k a d e m i s y e n. c o m UYARI Bu üründe yer alan bilgiler sadece lisanslı tıbbi çalışanlar için kaynak olarak sunulmuştur. Herhangi bir konuda profesyonel tıbbi danışmanlık veya tıbbi tanı amacıyla kullanılmamalıdır. Akademisyen Kitabevi ve alıcı arasında herhangi bir şekilde doktor-hasta, terapist-hasta ve/veya başka bir sağlık sunum hizmeti ilişkisi oluşturmaz. Bu ürün profesyonel tıbbi kararların eşleniği veya yedeği değildir. Akademisyen Kitabevi ve bağlı şirketleri, yazarları, katılımcıları, partnerleri ve sponsorları ürün bilgilerine dayalı olarak yapılan bütün uygulamalardan doğan, insanlarda ve cihazlarda yaralanma ve/veya hasarlardan sorumlu değildir. İlaçların veya başka kimyasalların reçete edildiği durumlarda, tavsiye edilen dozunu, ilacın uygulanacak süresi, yöntemi ve kontraendikasyonlarını belirlemek için, okuyucuya üretici tarafından her ilaca dair sunulan güncel ürün bilgisini kontrol etmesi tavsiye edilmektedir. Dozun ve hasta için en uygun tedavinin belirlenmesi, tedavi eden hekimin hastaya dair bilgi ve tecrübelerine dayanak oluşturması, hekimin kendi sorumluluğundadır. Akademisyen Kitabevi, üçüncü bir taraf tarafından yapılan kitaba dair değişikliklerden sorumlu değildir.

  • Top Cited Papers

    RIPK1/RIPK3/MLKL Necrosome Contributes to the Sepsis-Induced Cardiorenal Necroptotic Inflammatory Injury and Mortality

    by Bahar Tunctan, Muhammed Ahmed-Reda Elosman, Sefika Pinar Senol, Elif Ikiz, Tuba Kara

    Introduction: Due to its critical role in inflammation and necroptotic cell death, RIPK1 has been considered a prominent therapeutic drug target for managing a wide variety of diseases, including sepsis. Therefore, we aimed to investigate whether the RIPK1-driven necroptotic pathway contributes to the nitrosative stress-mediated cardiorenal inflammatory necroptotic injury and mortality using RIPK1 inhibitor, Nec-1s, in the murine sepsis model induced by LPS. Methods: Experiments were performed using mice injected intraperitoneally with DMSO or Nec-1s with saline and/or LPS. Following euthanasia and 6 hours after the injection of these agents, arteriovenous blood samples, hearts, and kidneys of the animals were collected. Serum MPO, iNOS, CKMB, creatinine, and HMGB1 levels were measured by ELISA. Associated proteins were measured by immunoblotting. H&E staining was used to evaluate histopathological changes in the tissues. In the mortality studies, the mice were monitored every 6 hours for mortality up to 96 hours after saline, LPS, DMSO, and/or Nec-1s injection. Results: In the LPS-injected mice, a rise in serum MPO, iNOS, CK-MB, creatinine, and HMGB1 levels was associated with the enhanced expression/activity of RIPK1/RIPK3/MLKL necrosome, HMGB1, iNOS, nitrotyrosine, gp91phox, and p47phox, in addition to scores related to histopathological changes in their tissues. Nec-1s attenuated the LPS-induced changes. Mortality rates of 10%, 50%, and 60% were observed at the 24th, 36th, and 48th hours, respectively, in the LPS-treated mice. When endotoxemic mice were treated with Nec-1s, mortality rates were 60%, 90%, and 100% at 18, 30, and 42 hours, respectively. Conclusion: These findings suggest that RIPK1/RIPK3/MLKL necrosome contributes to not only LPS-induced nitrosative stress-mediated cardiorenal inflammatory necroptotic injury, but also mortality.


  • Open Access

    mTOR inhibition modulates apoptosis and oxidative stress in hindlimb ischemia/reperfusion injury

    by Zarife Pi̇re, Demet Sinem Güden, Meryem Temi̇z Reşi̇toğlu, Sefika Pınar Şenol, Özden Vezi̇r, Nehir Sucu, Bahar Tunçtan, Kafait U. Mali̇k, Seyhan Şahan Firat

    Purpose: Ischemia/reperfusion (I/R)-induced injuries represent serious clinical events regarding profound target organ destructions followed by remote organ complications due to the loss of oxidant/antioxidant balance and apoptosis. Recent studies examining the mammalian target of rapamycin (mTOR) during I/R injury in different organs have remained a matter of debate. The current study aimed to explore further the protective and underlying antiapoptotic and antioxidant mechanisms of mammalian target of rapamycin (mTOR) inhibition in hindlimb (HL) schemia/reperfusion (I/R)injury. Materials and Methods: Occlusion of bilateral hindlimbs for 4 h with tourniquets was carried out under anesthesia to induce I/R for 4 h in rats. Rapamycin (1 mg/kg) or saline (4 mL/kg) was injected intraperitoneally 1 h before reperfusion. Gastrocnemius muscle, kidney, and blood were collected at the end of the experiments for analysis. Muscle and kidney damages were evaluated by measuring protein expression and/or phosphorylation of eukaryotic initiation factor 4E-binding protein 1 (4EBP1), ribosomal protein S6 (rpS6), B-cell lymphoma 2 (Bcl-2), caspase-3, and Bcl-2-associated X protein (Bax) with NADPH oxidase level and total antioxidant capacity in tissues or sera. Results: I/R-induced organ damages were demonstrated by enhanced phosphorylation and/or expression of rpS6, 4EBP1, caspase-3, and Bax with a significant reduction in Bcl-2 accompanied by a decreased total antioxidant capacity and increased level of NADPH oxidase. Administration of rapamycin, an inhibitor mTOR, protected against I/R-mediated injuries. Conclusion: Our findings suggest that the activation of mTOR signaling plays a crucial role in HL I/R-triggered organ damages presumably through the activation of apoptosis as a result of oxidant/antioxidant imbalance.


  • Open Access

    Inhibition of mTOR protects against skeletal muscle and kidney injury following hindlimb ischemia-reperfusion in rats by regulating MEK1/ERK1/2 activity

    by Çağla Akinci Uysal, Meryem Temi̇z Reşi̇tOğlu, Demet Sinem Güden, Sefika Pınar Şenol, Özden Vezi̇r, Nehir Sucu, Bahar Tunçtan, Kafait U. Mali̇k, Seyhan Firat

    Purpose: We have previously demonstrated that activation of the mammalian target of rapamycin (mTOR)/inhibitory-κB-α/nuclear factor-κB p65 signaling pathway mediates organ injuries through increased oxidative/nitrosative stress and inflammatory response in rat models of hind limb ischemia/reperfusion (HL I/R). Following up our previous findings regarding I/R injury through mammalian target of rapamycin (mTOR), we aimed to focus on the possible interaction between mammalian target of rapamycin (mTOR and mitogen-activated protein kinase kinase (MEK)1/extracellular signal-regulated kinase (ERK) 1/2 pathway in hind limb ischemia/reperfusion (HL I/R) resulting in target and remote organ injuries in the present study. Materials and Methods: Male Wistar rats were divided into four groups. HL I/R was induced by occluding with tourniquets of both hind limbs. Following 4 h, the tourniquets were removed following reperfusion for 4 h. After 4 h of reperfusion blood, kidney, and gastrocnemius muscle were collected. Results: HL I/R caused an increase in phosphorylation and/or expression of rpS6, MEK1, ERK1/2, tumor necrosis factor-α, inducible nitric oxide synthase, gp91phox, p22phox, and nitrotyrosine as well as nitrite levels in gastrocnemius muscle, kidney, and/or serum. Additionally, nicotinamide adenine dinucleotide phosphate oxidase and myeloperoxidase levels were increased in the tissues of rats subjected to HL I/R. Rapamycin, the selective inhibitor of mTOR, abolished all the effects mentioned above caused by HL I/R in the rat’s muscle and kidney. Conclusion: These data suggest that activation of the MEK1/ERK1/2 pathway contributes to mTOR-mediated HL I/R-induced target and remote organ injury.


  • Open Access

    Experimental Models in Neuroinflammatory Diseases: Systematic Review

    by Ömer Bahçeli̇, Şefika Pınar Şenol, Bahar Tunçtan

    Santral sinir sisteminde, inflamasyon gelişmesi nörolojik hastalıkların önemli ancak iyi anlaşılmamış bir durumudur. Akut beyin zedelenmesi veya enfeksiyonun ardından, astrositler ve mikrogliyanın etkinleşmesine ek olarak, kompleman faktörleri, sitokinler ve akut faz proteinlerinin oluşumundaki artmayı içeren karmaşık bir inflamatuar yanıt ortaya çıkmaktadır. T lenfositler ve antikorlar da ortaya çıkan bu yanıta katkıda bulunabilir. Zedelenmenin düzeltilmesinin daha güç, ancak kalıcı olduğu nörodejeneratif hastalıklarda inflamatuar yanıt süreklidir. Sürekli olan bu yanıtın başlıca amacı, ölen hücreler veya kümelenmiş proteinlerin temizlenmesi ile onarım işleminin başlatılmasının yanı sıra, dejenerasyon ve hücre ölümüne katkıda bulunma girişimidir. Hayvan modelleri, özgül inflamatuar mediyatörlerin nöroinflamatuar hastalıkların patojenezine katkısını araştırmak ve bu konuda yapılacak olan klinik araştırmalara temel oluşturabilecek bilgiler edinebilmek amacıyla kullanılmaktadır. Nöroinflamatuar hastalıkların oluşum mekanizmalarının ortaya konulması ve yeni tedavilerin geliştirilmesi ancak bu hastalıkların, deney hayvanlarında çalışılabilmesine olanak sağlayabilecek, deneysel modellerin oluşturulmasıyla gerçekleştirilebilir. Nörodejeneratif inflamatuar hastalıklar ile ilgili olarak elde edilecek daha fazla yeni veri, nöroinflamatuar hastalıkların insanlardaki klinik durumu en iyi derecede yansıtabilecek uygun deneysel modellerinin geliştirilmesine olanak tanıyabilecektir. Bu derlemede, en sık görülen Alzheimer hastalığı, Parkinson hastalığı, Hungtington hastalığı ile amyotrofik lateral skleroz gibi nöroinflamatuar hastalıkların kliniğinin yanı sıra, deneysel modellemesinde sıklıkla kullanılan transgenik ve transgenik olmayan yöntemler üzerinde durulmuştur. Ayrıca bu yöntemlerin sınırlamaları, avantajları ve dezavantajlarına değinilmiştir.